𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users

✍ Scribed by K.M. Roy; D.J. Goldberg; S. Hutchinson; S.O. Cameron; K. Wilson; L. MacDonald

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
63 KB
Volume
74
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

While much is known about hepatitis C virus (HCV) among injecting drug users (IDUs), there is scant information about the risk of HCV infection to non‐injecting sexual partners of injecting drug users; it is possible that such individuals may have a greater risk of acquiring HCV than any other group barring injecting drug users. This study examines the prevalence of HCV among a population of non‐injecting sexual partners of injecting drug users. Unlinked anonymous testing for anti‐HCV of residual sera stored following the named HIV testing of specimens originally from persons who had indicated to their attending clinicians that they were non‐injecting sexual partners of injecting drug users. The prevalence of anti‐HCV among the sexual partners was 4.1% (25/611) overall, 6.4% (13/202) among heterosexual male and 3.0% (12/397) among the heterosexual female partners. None of the homosexual/bisexual partners were HCV antibody positive (0/12). Although we cannot be sure how non‐injecting partners of injecting drug users acquire their HCV infection, having a relationship with someone who injects drugs may place an individual at appreciable risk of being infected; such individuals should consider being tested for HCV. J. Med. Virol. 74:62–66, 2004. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Molecular analysis of hepatitis C virus
Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users
✍ Massimo Ciccozzi; Gianni Zehender; Valeria Cento; Alessandra Lo Presti; Pavel Te 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 1 views

## Abstract Intravenous drug users constitute a group at risk for hepatitis C virus (HCV) infection. Today, no data are available on the molecular epidemiology of HCV in Bulgaria despite the fact that in recent years the incidence of acute hepatitis C infection among Bulgarian intravenous drug user

Molecular epidemiology of hepatitis C vi
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users
✍ Yoann Morice; Jean-François Cantaloube; Stéphanie Beaucourt; Laetitia Barbotte; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

## Abstract Hepatitis C virus subtype 3a (HCV‐3a) originates from Asia and has spread widely among injecting drug users as well as other patient groups in industrialized countries. HCV subtype 3a infection remains highly prevalent and frequently transmitted in the population of intravenous drug use

Prevalence of hepatitis B virus and risk
Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users
✍ Renata C. Ferreira; Fabiana P. Rodrigues; Sheila A. Teles; Carmen L.R. Lopes; An 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Abstract Non‐injecting drug users are at high‐risk for acquiring hepatitis B virus (HBV), although the factors contributing to this increased risk are not known. In the present study, the overall and occult HBV infection prevalence rates were determined in a large population of non‐injecting dru

High incidence of hepatitis C virus rein
High incidence of hepatitis C virus reinfection in a cohort of injecting drug users
✍ Campbell Kynoch Aitken; Jennifer Lewis; Samantha Lilly Tracy; Timothy Spelman; D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 1 views

An estimated 170 million people worldwide carry the hepatitis C virus (HCV), and in more developed countries the prevalence and incidence of HCV is particularly high among injecting drug users (IDUs). Spontaneous clearance of HCV infection and reinfection is well recognized but the level of protecti

Distribution of hepatitis C virus genoty
Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004–2005
✍ M.I. Micalessi; C. Gérard; L. Ameye; S. Plasschaert; B. Brochier; R. Vranckx 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract The aim of this study was to determine the current prevalence of HCV genotypes in injecting drug users recruited at treatment centers all over Belgium, and to analyze if the distribution of genotypes was correlated with demographic characteristics, at‐risk behaviors, and co‐infection wi